Try our Advanced Search for more refined results
February 27, 2014
Takeda Pharmaceuticals USA Inc. v. Watson Laboratories Inc.
Case Number:
1:14-cv-00268
Court:
Nature of Suit:
Judge:
Firms
Companies
Sectors & Industries:
View recent docket activity
Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.
Coverage
-
January 12, 2016
Takeda's Gout Drug IP Case Paused After Deal With Watson
A Delaware federal judge on Tuesday pushed pause on Takeda's patent infringement suit seeking to block Watson Laboratories from producing a generic version of the gout treatment Colcrys after the parties reached a settlement that is pending review by federal regulators.
Parties
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
- Direct access to case information and documents.
- All significant new filings across U.S. federal district courts, updated hourly on business days.
- Full-text searches on all patent complaints in federal courts.
- No-fee downloads of the complaints and so much more!
TRY LAW360 FREE FOR SEVEN DAYS
Already a subscriber? Click here to login